PMID: 30021104Jul 19, 2018Paper

Novel targeted therapies in ovarian and uterine carcinosarcomas

Discovery Medicine
Chanhee HanAlessandro D Santin

Abstract

Carcinosarcomas (CSs) of the uterus and ovary are rare biologically aggressive tumors with poor prognosis. The development of novel, effective treatment strategies against CSs of the female genital tract remains an unmet medical need. Whole-exome sequencing studies have recently demonstrated mutations or aberrant activation of multiple genes/pathways in CSs including HER2, PI3K/AKT/mTOR, EGFR, MAPK, genes related to histones and chromatin structure, and genes related to cell-cycle regulation. The carcinomatous component of these biphasic tumors is suggested to be the catalyst in CS tumorigenesis. This article reviews the genetic landscapes and explores novel targeted treatment modalities against this deadly gynecologic tumor.

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Gunjal GargRobert T Morris
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
Zhe JinTeiichi Motoyama
The Journal of Reproductive Medicine
Alireza AbidiMasoud Azodi
© 2022 Meta ULC. All rights reserved